| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACET | Exit | Adicet Bio, Inc. | $0 | – | -200,201 | -100.0% | -0.09% | – |
| Exit | GeneDx Holdings Corp. | $0 | – | -103,604 | -100.0% | -0.13% | – | |
| Exit | Pyxis Oncology, Inc (formerly Apexigen) | $0 | – | -326,810 | -100.0% | -0.22% | – | |
| MRSN | Exit | Mersana Therapeutics, Inc. | $0 | – | -904,268 | -100.0% | -0.38% | – |
| SCYX | Exit | Scynexis Inc. | $0 | – | -555,555 | -100.0% | -0.42% | – |
| ATRC | Exit | AtriCure Inc. | $0 | – | -46,259 | -100.0% | -0.68% | – |
| Exit | Aadi Bioscience, Inc. | $0 | – | -526,329 | -100.0% | -0.85% | – | |
| EQ | Exit | Equillium Inc. | $0 | – | -4,447,308 | -100.0% | -1.10% | – |
| TERN | Exit | Terns Pharmaceuticals, Inc. | $0 | – | -714,285 | -100.0% | -1.20% | – |
| BYSI | Exit | BeyondSpring Inc. | $0 | – | -4,958,143 | -100.0% | -1.32% | – |
| Exit | Cue Health Inc. | $0 | – | -8,980,909 | -100.0% | -1.32% | – | |
| SGEN | Exit | SEAGEN INC | $0 | – | -23,014 | -100.0% | -1.63% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -415,880 | -100.0% | -2.20% | – |
| PHAT | Exit | PHATHOM PHARMACEUTICALS INC | $0 | – | -850,000 | -100.0% | -2.94% | – |
| HZNP | Exit | Horizon Therapeutics PLC | $0 | – | -78,900 | -100.0% | -3.05% | – |
| LNTH | Exit | LANTHEUS HOLDINGS INC(NMS) | $0 | – | -142,196 | -100.0% | -3.30% | – |
| ILMN | Exit | Illumnia, Inc. | $0 | – | -80,859 | -100.0% | -3.70% | – |
| PACB | Exit | Pacific Biosciences of California, Inc. | $0 | – | -1,463,872 | -100.0% | -4.08% | – |
| ARGX | Exit | Argenx SE | $0 | – | -27,429 | -100.0% | -4.50% | – |
| TXG | Exit | 10x Genomics, Inc. | $0 | – | -359,554 | -100.0% | -4.95% | – |
| RCUS | Exit | Arcus Biosciences, Inc | $0 | – | -869,790 | -100.0% | -5.21% | – |
| Exit | ACELYRIN INC(NSM) | $0 | – | -1,548,317 | -100.0% | -5.26% | – | |
| Exit | ROIVANT SCIENCES LTD | $0 | – | -1,459,700 | -100.0% | -5.69% | – | |
| Exit | Aura Biosciences, Inc. | $0 | – | -1,163,123 | -100.0% | -6.09% | – | |
| ZNTL | Exit | Zentalis Pharmaceuticals Inc. | $0 | – | -2,099,583 | -100.0% | -14.06% | – |
| ALPN | Exit | Alpine Immune Sciences, Inc. | $0 | – | -6,708,288 | -100.0% | -25.63% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Illumnia, Inc. | 7 | Q3 2023 | 16.5% |
| Cue Health Inc. | 7 | Q3 2023 | 17.8% |
| Arcus BioSciences, Inc. | 7 | Q3 2023 | 8.4% |
| 10x Genomics, Inc. | 7 | Q3 2023 | 8.1% |
| Pacific Biosciences of California, Inc. | 7 | Q3 2023 | 6.8% |
| Equillium Inc. | 7 | Q3 2023 | 4.3% |
| Aadi Bioscience, Inc. | 7 | Q3 2023 | 2.7% |
| Adicet Bio, Inc. | 7 | Q3 2023 | 3.6% |
| Aura Biosciences, Inc. | 7 | Q3 2023 | 6.1% |
| Terns Pharmaceuticals, Inc. | 7 | Q3 2023 | 3.4% |
View Decheng Capital Management III (Cayman), LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-01-22 |
| 13F-HR/A | 2023-12-12 |
| 13F-HR/A | 2023-11-29 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-07-28 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-08 |
| 4 | 2022-09-27 |
| 13F-HR | 2022-08-01 |
View Decheng Capital Management III (Cayman), LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.